Brenntag (BNR) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
13 May, 2026Executive summary
Q1 2026 began with subdued demand and weak market activity, but momentum improved from mid-March due to swift crisis response, commercial agility, and price increases following Middle East disruptions.
The company demonstrated resilience and agility, leveraging its integrated business model, flatter organization, and supply reliability to maintain value creation amid volatility.
Cost-out program delivered EUR 27 million in Q1 savings, supporting profitability and on track for EUR 200–250 million in annual savings by 2027.
Strategic focus remains on organic growth, commercial execution, and leveraging the full product portfolio, with a Capital Markets Day set for November 12, 2026.
Acquisition of Airedale Group in the UK completed, enhancing service and product capabilities in EMEA.
Financial highlights
Sales were EUR 3.7 billion, down 5.1% year-over-year (fx adjusted), with operating gross profit at EUR 950 million, down 1.3% year-over-year, and gross margin up 0.9 percentage points to 25.9%.
Operating EBITDA was EUR 306 million, down 8.3% year-over-year; operating EBITA was EUR 217 million, down 12.6%.
Profit after tax was EUR 98 million; EPS was EUR 0.68, down from EUR 0.93 in Q1 2025.
Free cash flow was EUR 91 million, down from EUR 163 million in Q1 2025, impacted by higher working capital needs.
Outlook and guidance
Full-year 2026 operating EBITDA guidance confirmed at EUR 1,150–1,350 million, with confidence in Q2 performance but uncertainty for H2 due to unpredictable demand and geopolitical risks.
Supply chains expected to normalize within 6–12 months if Middle East tensions de-escalate.
Strategy update planned for Capital Markets Day on November 12, 2026.
Latest events from Brenntag
- Resilient Q1 2026 results, strong margins, and confirmed 2026 EBITDA guidance amid market volatility.BNR
Investor presentation13 May 2026 - Gross margin and cash flow rose despite lower earnings, with cost savings and cautious outlook.BNR
Q4 202525 Apr 2026 - Resilient FY 2024 performance with strong cash flow, cost-out, and sustainability leadership.BNR
Investor presentation12 Mar 2026 - Board renewal, enhanced remuneration, and ESG leadership drive governance excellence.BNR
Investor presentation17 Feb 2026 - Q2 and H1 2024 saw lower sales, EBITA, and cash flow, with guidance revised down.BNR
Q2 20241 Feb 2026 - Sales and gross profit rose, but EBITA, EPS, and free cash flow declined; guidance reaffirmed.BNR
Q3 202414 Jan 2026 - Sales and EBITA fell, but free cash flow and cost savings improved; guidance at lower end.BNR
Q3 202512 Dec 2025 - Sales and EBITDA fell, but cost savings and M&A support stability amid tough markets.BNR
Q4 20244 Dec 2025 - Stable Q1 sales and profit, but net income and cash flow declined amid global uncertainty.BNR
Q1 202524 Nov 2025